Vol. 1 No. 2 (2016): Advances in Precision Medicine

Articles

• Personalized medicine: consequences for drug research and therapy

  Thorsten Ruppert, Sabine Sydow, Günter Stock

  DOI: 10.18063/APM.2016.02.004

• Precision medicine: do not neglect the hurdles

  Lilla Landeck, Patricia Carrigan, Khusru Asadullah

  DOI: 10.18063/APM.2016.02.005

• The role of open innovation in biomarker discovery

  Lilla Landeck, Monika Lessl, Andreas Busch, Matthias Gottwald, Khusru Asadullah

  DOI: 10.18063/APM.2016.02.007.

• Success factors in drug discovery and development

  Björn Wallmark

  DOI: 10.18063/APM.2016.02.002

• Reproducibility of preclinical data: one man's poison is another man's meat

  Anton Bespalov, Christoph H. Emmerich, Björn Gerlach, Martin C. Michel

  DOI: 10.18063/APM.2016.02.001

• Interleukin-17A blockade with secukinumab results in decreased neutrophil infiltration in psoriasis: minimally-invasive measurement by tape stripping

  Christian Loesche, Frank Kolbinger, Marie-Anne Valentin, Philip Jarvis, Melanie Ceci, Grazyna Wieczorek, Edward Khokhlovich, Irina Koroleva, Gerard Bruin, Frank Sinner, Birgit Aigner, Dhavalkumar D Patel

  DOI: 10.18063/APM.2016.02.003

• The research data reproducibility problem solicits a 21st century solution

  Bhupinder Bhullar

  DOI: 10.18063/APM.2016.02.006